Knowledge Base
Clear, current guidance on the regulations and processes that shape the pharmaceutical and healthcare industry in Greece and the EU.
Practical answers to complex questions
Our Knowledge Base collects PQRA’s articles and explainers on regulatory affairs, quality, drug safety and market access. It is written for pharmaceutical companies, medical device manufacturers and healthcare innovators who need to understand what the rules require — and what to do about them. The content is kept up to date as EU and Greek legislation evolves. It is provided for general information and is not a substitute for tailored regulatory or legal advice.
Regulatory Affairs
Marketing authorisations, eCTD submissions, variations and lifecycle management, orphan designation, paediatric plans, clinical trials and the EU HTA Regulation.
Read articles →Quality Assurance
GMP and GDP, Annex 1 and contamination control, inspection readiness, audits, qualified-person release, serialisation and impurity control.
Read articles →Pharmacovigilance
The QPPV, the PSMF, signal detection, PSURs and risk-management plans — building and running a compliant drug-safety system.
Read articles →Market Access & HTA
Reimbursement in Greece, the Joint Clinical Assessment, pricing and clawback, managed-entry agreements, real-world evidence and access for rare diseases and biosimilars.
Read articles →Medical Devices
The EU MDR and IVDR, transition deadlines, classification, technical documentation and EUDAMED.
Read articles →Ask an Expert
Can’t find what you need? Put your question to our consultants and we will point you in the right direction.
Get in touch →Need advice on your specific situation?
The Knowledge Base gives you the background — our team gives you the plan. Book a consultation to discuss your product.
Contact PQRA